{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:13:08Z","timestamp":1763637188122,"version":"3.45.0"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.gene.2025.149816","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:42:11Z","timestamp":1760071331000},"page":"149816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Editors\u2019 Corner: RESTORE-ing Hope\u2014RNA Editing as a Frontier in Cystic Fibrosis Therapy"],"prefix":"10.1016","volume":"972","author":[{"given":"By Marianna","family":"Kruithof-de Julio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2025.149816_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2025.149384","article-title":"RNA editing applied to cystic fibrosis: RESTORE can target G542X CFTR mRNA and revert the nonsense mutation","volume":"951","author":"Titoli","year":"2025","journal-title":"Gene"},{"key":"10.1016\/j.gene.2025.149816_b0010","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.3390\/ijms21134781","article-title":"Investigating REPAIRv2 as a Tool to Edit CFTR mRNA with Premature Stop Codons","volume":"21","author":"Melfi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2025.149816_b0015","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00018-025-05587-y","article-title":"Adenine base editing of CFTR using receptor targeted nanoparticles restores function to G542X cystic fibrosis airway epithelial cells","volume":"82","author":"Rose","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.gene.2025.149816_b0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41587-019-0013-6","article-title":"Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides","volume":"37","author":"Merkle","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.gene.2025.149816_b0025","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/d41573-024-00070-y","article-title":"RNA-editing drugs advance into clinical trials","volume":"23","author":"Mullard","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.gene.2025.149816_b0030","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf675","article-title":"ACE-tRNAs are a platform technology for suppressing nonsense mutations that cause cystic fibrosis","volume":"53","author":"Ko","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.gene.2025.149816_b0035","article-title":"Prime editing-mediated correction of the CFTR W1282X mutation in iPSCs and derived airway epithelial cells","volume":"18","author":"Li","year":"2023","journal-title":"PLoS One"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111925006055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111925006055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:10:16Z","timestamp":1763637016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111925006055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":7,"alternative-id":["S0378111925006055"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2025.149816","relation":{},"ISSN":["0378-1119"],"issn-type":[{"type":"print","value":"0378-1119"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editors\u2019 Corner: RESTORE-ing Hope\u2014RNA Editing as a Frontier in Cystic Fibrosis Therapy","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2025.149816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149816"}}